Embracing Future Holdings (SGX:8YY) Other Stockholders Equity: S$2.75 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Embracing Future Holdings Other Stockholders Equity?

Embracing Future Holdings SGX:8YY Other Stockholders Equity is S$2.75 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Embracing Future Holdings's Other Stockholders Equity for the quarter that ended in Dec. 2025 was S$2.75 Mil.

Embracing Future Holdings's quarterly Other Stockholders Equity increased from Dec. 2024 (S$1.10 Mil) to Jun. 2025 (S$1.11 Mil) and increased from Jun. 2025 (S$1.11 Mil) to Dec. 2025 (S$2.75 Mil).

Embracing Future Holdings's annual Other Stockholders Equity increased from Dec. 2023 (S$0.02 Mil) to Dec. 2024 (S$1.10 Mil) and increased from Dec. 2024 (S$1.10 Mil) to Dec. 2025 (S$2.75 Mil).

Embracing Future Holdings Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Embracing Future Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embracing Future Holdings Other Stockholders Equity Chart

Embracing Future Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.01 0.02 1.10 2.75

Embracing Future Holdings Quarterly Data
Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.09 1.10 1.11 2.75

Embracing Future Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of S$2.75 Mil mean?
Embracing Future Holdings (SGX:8YY) has a Other Stockholders Equity of S$2.75 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Embracing Future Holdings and its competitors.
Is Embracing Future Holdings' Other Stockholders Equity too high?
Embracing Future Holdings' current Other Stockholders Equity is S$2.75 Mil.
How does Embracing Future Holdings' Other Stockholders Equity compare to TMO and DHR?
Embracing Future Holdings' Other Stockholders Equity of S$2.75 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Embracing Future Holdings and its competitors. Embracing Future Holdings's current Other Stockholders Equity is S$2.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embracing Future Holdings stock overvalued right now?
Embracing Future Holdings (SGX:8YY) has a current Other Stockholders Equity of S$2.75 Mil. The current Other Stockholders Equity is S$2.75 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Embracing Future Holdings (SGX:8YY), the current Other Stockholders Equity is S$2.75 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Embracing Future Holdings Business Description

Address 122 Emerald Hill Road, Singapore, SGP, 229405
Embracing Future Holdings Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, Advertising, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports. Its operations are spread across Singapore, Japan, China, Europe, Hong Kong, Thailand, Malaysia, and other countries.